High expression of urinary hormone‐type plasminogen activating factor mRNA correlates with poor overall and disease‐free survival in pancreatic cancer patients, as Professor Winter [21] described their research confirms a positive correlation between uPA serum levels and CA19‐9, as well as the negative prognostic impact of elevated uPA concentrations in pancreatic cancer patients. The gene discussed is PLAU; the disease is pancreatic neoplasm.